SIGAL ELLIOT 4
4 · Spark Therapeutics, Inc. · Filed Jun 3, 2019
Insider Transaction Report
Form 4
SIGAL ELLIOT
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2019-05-30−1,500→ 0 total→ Common Stock (1,500 underlying) - Exercise/Conversion
Common Stock
2019-05-30+1,500→ 14,214 total
Footnotes (3)
- [F1]Each restricted stock unit converted into one share of Spark Therapeutics, Inc. common stock.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Spark Therapeutics, Inc. common stock.
- [F3]On May 30, 2018, the reporting person was granted 1,500 restricted stock units that vest on the one-year anniversary of the grant date. Vested shares are delivered to the reporting person on the vesting date.